SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 141 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $25,000 | +13.6% | 13,800 | +38.0% | 0.00% | 0.0% |
| Q4 2017 | $22,000 | -24.1% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $29,000 | -50.0% | 10,000 | -22.8% | 0.00% | -33.3% |
| Q2 2017 | $58,000 | -3.3% | 12,952 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $60,000 | -24.1% | 12,952 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $79,000 | +43.6% | 12,952 | +29.5% | 0.00% | +33.3% |
| Q3 2016 | $55,000 | +44.7% | 10,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $38,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
| Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
| WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
| BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
| Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
| Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
| BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
| HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
| BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |